HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A M Zeidan Selected Research

fedratinib

12/2020Fedratinib hydrochloride to treat intermediate-2 or high-risk primary or secondary myelofibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A M Zeidan Research Topics

Disease

2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2017 - 01/2017
1Anemia
12/2020
1Neoplasms (Cancer)
12/2020
1Primary Myelofibrosis (Myelosclerosis)
12/2020

Drug/Important Bio-Agent (IBA)

1fedratinibIBA
12/2020
1Transaminases (Aminotransferases)IBA
12/2020

Therapy/Procedure

2Therapeutics
11/2017 - 01/2017